Antiresorptive medication in oncology: the clinical and dental profile of patients in a reference center |
Ferreira, Vitor Hugo Candido
(Department of Stomatology, Federal University of Parana)
Kemp, Aristilia Tahara (Department of Stomatology, Federal University of Parana) Vendruscolo, Joana (Department of Oral and Maxillofacial Surgery, Erasto Gaertner Cancer Center) Sassi, Laurindo Moacir (Department of Oral and Maxillofacial Surgery, Erasto Gaertner Cancer Center) Schussel, Juliana Lucena (Department of Stomatology, Federal University of Parana) |
1 | Gaudin E, Seidel L, Bacevic M, Rompen E, Lambert F. Occurrence and risk indicators of medication-related osteonecrosis of the jaw after dental extraction: a systematic review and meta-analysis. J Clin Periodontol 2015;42:922-32. https://doi.org/10.1111/jcpe.12455 DOI |
2 | Tsurushima H, Kokuryo S, Sakaguchi O, Tanaka J, Tominaga K. Bacterial promotion of bisphosphonate-induced osteonecrosis in Wistar rats. Int J Oral Maxillofac Surg 2013;42:1481-7. https://doi.org/10.1016/j.ijom.2013.06.011 DOI |
3 | Dimopoulos MA, Kastritis E, Bamia C, Melakopoulos I, Gika D, Roussou M, et al. Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid. Ann Oncol 2009;20:117-20. https://doi.org/10.1093/annonc/mdn554 DOI |
4 | Bramati A, Girelli S, Farina G, Dazzani MC, Torri V, Moretti A, et al. Prospective, mono-institutional study of the impact of a systematic prevention program on incidence and outcome of osteonecrosis of the jaw in patients treated with bisphosphonates for bone metastases. J Bone Miner Metab 2015;33:119-24. https://doi.org/10.1007/s00774-014-0566-x DOI |
5 | Sahin O, Odabasi O, Aliyev T, Tatar B. Risk factors of medication-related osteonecrosis of the jaw: a retrospective study in a Turkish subpopulation. J Korean Assoc Oral Maxillofac Surg 2019;45:108-15. https://doi.org/10.5125/jkaoms.2019.45.2.108 DOI |
6 | Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, et al. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. J Oral Maxillofac Surg 2014;72:1938-56. https://doi.org/10.1016/j.joms.2014.04.031 DOI |
7 | Nifosi AF, Zuccarello M, Nifosi L, Hervas Saus V, Nifosi G. Osteonecrosis of the jaw in the era of targeted therapy and immunotherapy in oncology. J Korean Assoc Oral Maxillofac Surg 2019;45:3-8. https://doi.org/10.5125/jkaoms.2019.45.1.3 DOI |
8 | Al Abdullateef A, Alhareky MS. Awareness among patient at risk of developing Medication Related Osteonecrosis of the Jaw (MRONJ) - a primary prevention strategy. Saudi Pharm J 2020;28:771-8. https://doi.org/10.1016/j.jsps.2020.05.004 DOI |
9 | Sturrock A, Preshaw PM, Hayes C, Wilkes S. Perceptions and attitudes of patients towards medication-related osteonecrosis of the jaw (MRONJ): a qualitative study in England. BMJ Open 2019;9:e024376. https://doi.org/10.1136/bmjopen-2018-024376 DOI |
10 | Nicolatou-Galitis O, Schiodt M, Mendes RA, Ripamonti C, Hope S, Drudge-Coates L, et al. Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment. Oral Surg Oral Med Oral Pathol Oral Radiol 2019;127:117-35. https://doi.org/10.1016/j.oooo.2018.09.008 DOI |
11 | Coleman RE. Skeletal complications of malignancy. Cancer 1997;80(8 Suppl):1588-94. https://doi.org/10.1002/(sici)1097-0142(19971015)80:8+<1588::aid-cncr9>3.3.co;2-z DOI |
12 | Greene JC, Vermillion JR. The simplified oral hygiene index. J Am Dent Assoc 1964;68:7-13. https://doi.org/10.14219/jada.archive.1964.0034 DOI |
13 | Patel V, Kelleher M, Sproat C, Kwok J, McGurk M. New cancer therapies and jaw necrosis. Br Dent J 2015;219:203-7. https://doi.org/10.1038/sj.bdj.2015.680 DOI |
14 | Heufelder MJ, Hendricks J, Remmerbach T, Frerich B, Hemprich A, Wilde F. Principles of oral surgery for prevention of bisphosphonate-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol 2014;117:e429-35. https://doi.org/10.1016/j.oooo.2012.08.442 DOI |
15 | Tsao C, Darby I, Ebeling PR, Walsh K, O'Brien-Simpson N, Reynolds E, et al. Oral health risk factors for bisphosphonate-associated jaw osteonecrosis. J Oral Maxillofac Surg 2013;71:1360-6. https://doi.org/10.1016/j.joms.2013.02.016 DOI |
16 | Sandhu S, Salous MH, Sankar V, Margalit DN, Villa A. Osteonecrosis of the jaw and dental extractions: a single-center experience. Oral Surg Oral Med Oral Pathol Oral Radiol 2020;130:515-21. https://doi.org/10.1016/j.oooo.2020.07.001 DOI |
17 | Poubel VLDN, Silva CAB, Mezzomo LAM, De Luca Canto G, Rivero ERC. The risk of osteonecrosis on alveolar healing after tooth extraction and systemic administration of antiresorptive drugs in rodents: a systematic review. J Craniomaxillofac Surg 2018;46:245-56. https://doi.org/10.1016/j.jcms.2017.11.008 DOI |
18 | Landesberg R, Woo V, Cremers S, Cozin M, Marolt D, Vunjak-Novakovic G, et al. Potential pathophysiological mechanisms in osteonecrosis of the jaw. Ann N Y Acad Sci 2011;1218:62-79. https://doi.org/10.1111/j.1749-6632.2010.05835.x DOI |